A week ago, MedPageToday reported that a British advisory commission recommended the diabetes drug rosiglitazone (Avandia) be withdrawn from the market.
On July 6, I wrote about evidence that rosiglitazone users seem to incur a higher risk of stroke, heart failure, and death.
If I were taking Avandia, I’d be asking my doctor about alternatives.
Diabetic Mediterranean Diet 
Pingback: Rosiglitazone On the Ropes | Blood Glucose Test Strips
Pingback: R.I.P., Rosiglitazone | Diabetic Mediterranean Diet